What’s so important about the decision to submit your RxDC Drug Cost Reporting and why you want to access your data?
Join industry experts Join Drew Kallestad, Co-Founder HPFid, Elliott Wynne, Sr. Sales Executive at CXC Solutions, and Harold Nations, Practice Leader at Healthcare Reporting to explore the RxDC Reporting requirements of the Consolidated Appropriations Act and what it means for your health plan spend.
With the recent passing of the June 1 deadline for reporting Consolidated Appropriations Act (CAA) required prescription drug data to government agencies,
In the ever-evolving landscape of healthcare, access to comprehensive data is a game-changer, offering unparalleled insights into utilization and cost. One significant
In an era marked by unprecedented disruption in healthcare, navigating the landscape can be daunting. Traditional pharmacy benefit managers (PBMs) have long
